ArticleFrontiers in oncology2025

Brexpiprazole inhibits EMT and migration of colorectal cancer cells by downregulating the SREBP1/SNAI1 signaling pathway.

Xiaojie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.